This inventor holds 1 USPTO granted patent. Top assignees: Jiangsu Nanfang Medical Co., Ltd., Zhejiang University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Liming Li: Innovator in Plant-Derived Exosome Technology
Introduction
Liming Li is a prominent inventor based in Zhejiang, China. He has made significant contributions to the field of biotechnology, particularly in the development of plant-derived exosomes for medical applications. His innovative work focuses on utilizing natural plant components to enhance tissue regeneration therapies.
Latest Patents
Liming Li holds a patent for a groundbreaking invention titled "Plant-derived exosome as well as preparation method and application thereof." This patent discloses a method for preparing plant-derived exosomes that can be used in drug development and scaffolding for animal tissue regeneration therapy. The preparation method involves soaking and infiltrating parts of a natural plant with a specific buffer solution, followed by a series of centrifugation processes to extract the exosomes. This innovative approach has the potential to revolutionize regenerative medicine.
Career Highlights
Throughout his career, Liming Li has worked with esteemed institutions, including Zhejiang University and Jiangsu Nanfang Medical Co., Ltd. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to significant advancements in biotechnology.
Collaborations
Liming Li has collaborated with notable colleagues such as Jianqing Gao and Jiachen Chen. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Liming Li's work in plant-derived exosome technology exemplifies the intersection of nature and science, paving the way for new therapeutic approaches in medicine. His contributions are a testament to the potential of innovative thinking in addressing complex medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile